PULM: Pulmatrix, Inc. Stock

by  •  • Comments Off on PULM: Pulmatrix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23.16
Enterprise Value ($M) 13.63
Book Value ($M) 8.95
Book Value / Share 2.45
Price / Book 2.59
NCAV ($M) 8.92
NCAV / Share 2.44
Price / NCAV 2.59

Profitability (mra)
Return on Invested Capital (ROIC) -1.07
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.50

Liquidity (mrq)
Quick Ratio 10.68
Current Ratio 10.68

Balance Sheet (mrq) ($M)
Current Assets 9.92
Assets 9.94
Liabilities 1.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.81
Operating Income -7.14
Net Income -9.56
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -10.72
Cash from Investing -0.40
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,958 12,327 15.88
2025-04-16 487 3,970 12.27
2025-04-15 1,240 11,882 10.44
2025-04-14 566 4,566 12.40

(click for more detail)

Similar Companies
PRTG – Portage Biotech Inc. PTIX – Protagenic Therapeutics, Inc.
PTPI – Petros Pharmaceuticals, Inc. QLGN – Qualigen Therapeutics, Inc.
QTTB – Q32 Bio Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Pulmatrix